MSB 7.69% $1.19 mesoblast limited

Ann: Trading Halt, page-113

  1. 693 Posts.
    lightbulb Created with Sketch. 266
    Frankly, I'm surprised that anyone is surprised by this announcement. Any experienced investor would have seen it as entirely predictable given the current share price and unknown and turbulent future market conditions.

    Bear in mind that, while MSB is showing a reasonable (but not healthy, in terms of month's cash burn) cash balance, it is more than offset by its debt obligations. Yep, there might be a partnership or strategic alliance out there, or GvHD might take off significantly faster than industry norms and give us some cash by year end, or MSC's might work and be financially viable in ARDS (despite failing to meet primary endpoints in COPD), or whatever. But the risks remain high (of course, with commensurately high returns as we all know).

    The Board is doing the only prudent thing and boosting its balance sheet while it can - full marks to them!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.